Found: 9
Select item for more details and to access through your institution.
Registries supporting new drug applications.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2017, v. 26, n. 12, p. 1451, doi. 10.1002/pds.4332
- By:
- Publication type:
- Article
Safety of continuing mineralocorticoid receptor antagonist treatment in patients with heart failure with reduced ejection fraction and severe kidney disease: Data from Swedish Heart Failure Registry.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2164, doi. 10.1002/ejhf.3049
- By:
- Publication type:
- Article
Eligibility for vericiguat in a real‐world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1418, doi. 10.1002/ejhf.2939
- By:
- Publication type:
- Article
Future of the drug label: Perspectives from a multistakeholder dialogue.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 10, p. 2442, doi. 10.1111/bcp.14070
- By:
- Publication type:
- Article
Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 7, p. 1507, doi. 10.1111/bcp.13923
- By:
- Publication type:
- Article
Safety‐Related Drug Label Changes Following Large Post‐Marketing Cardiometabolic Trials: A Review of European Public Assessment Reports.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 4, p. 859, doi. 10.1002/cpt.2840
- By:
- Publication type:
- Article
Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 2, p. 349, doi. 10.1002/cpt.2789
- By:
- Publication type:
- Article
Medication Adherence Measurement Methods in Registration Trials Supporting the Approval of New Medicines: A Cross‐Sectional Analysis of Centralized Procedures in the European Union 2010–2020.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 5, p. 1051, doi. 10.1002/cpt.2709
- By:
- Publication type:
- Article
Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 1, p. 69, doi. 10.1002/cpt.2554
- By:
- Publication type:
- Article